Search - tctmd.com

Displaying 941 - 960 of 972

Sort: Relevancy | Date

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

June 05, 2012

News Daily News

Several Factors Behind False-Positive STEMI Activations

Yael L. Maxwell

May 09, 2012

News Daily News

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

L.A. McKeown

April 25, 2012

News Daily News

Exenatide Only Cardioprotective in STEMI Patients Treated Quickly

Caitlin E. Cox

April 16, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Caitlin E. Cox

March 12, 2012

News Conference News Cell Therapy 2012

Expedited Cell Therapy After STEMI Shows Promise

January 29, 2012

News Daily News

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

L.A. McKeown

December 08, 2011

News Daily News

Hospital Readmission Post-PCI Linked to Increased Mortality

Yael L. Maxwell

December 05, 2011

News Conference News

Adenosine-Free Pressure Measurement Found Equivalent to FFR

L.A. McKeown

December 01, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

News Daily News

Study Proposes New CK-MB Threshold for Periprocedural MI

Caitlin E. Cox

October 12, 2011

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Conference News

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

September 01, 2011

News Daily News

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

August 03, 2011

News Daily News

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

August 01, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Statin Users Have Better Outcomes After PCI for Stable CAD

L.A. McKeown

July 08, 2011

News Daily News

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

L.A. McKeown

June 10, 2011

Advertisement

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

Meta-analysis Favors Intracoronary vs. Intravenous Abciximab in Primary PCI

Several Factors Behind False-Positive STEMI Activations

Meta-Analysis: First-Gen DES Show Long-term Safety, Efficacy in STEMI Setting

Exenatide Only Cardioprotective in STEMI Patients Treated Quickly

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Expedited Cell Therapy After STEMI Shows Promise

FFR-Guidance Demonstrates Benefits in Patients with Unstable Angina, NSTEMI

Hospital Readmission Post-PCI Linked to Increased Mortality

Adenosine-Free Pressure Measurement Found Equivalent to FFR

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Study Proposes New CK-MB Threshold for Periprocedural MI

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Japanese ACS Patients Fare Better with High Rates of Intensive Treatment

Excess Dyspnea with Ticagrelor Does Not Compromise Mortality Benefit

Studies Support Staged PCI for STEMI Patients with Multivessel Disease

Ticagrelor Gains FDA Approval for Use in ACS

Statin Users Have Better Outcomes After PCI for Stable CAD

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content